Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Sumitomo Pharma Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sumitomo Pharma Co Ltd
Cost of Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Cost of Revenue
-ÂĄ131.1B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cost of Revenue
-ÂĄ1.5T
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Daiichi Sankyo Co Ltd
TSE:4568
Cost of Revenue
-ÂĄ416.7B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Otsuka Holdings Co Ltd
TSE:4578
Cost of Revenue
-ÂĄ639.6B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cost of Revenue
-ÂĄ337.2B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Astellas Pharma Inc
TSE:4503
Cost of Revenue
-ÂĄ383.6B
CAGR 3-Years
-16%
CAGR 5-Years
-6%
CAGR 10-Years
-2%

See Also

What is Sumitomo Pharma Co Ltd's Cost of Revenue?
Cost of Revenue
-131.1B JPY

Based on the financial report for Jun 30, 2024, Sumitomo Pharma Co Ltd's Cost of Revenue amounts to -131.1B JPY.

What is Sumitomo Pharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%

Over the last year, the Cost of Revenue growth was 20%. The average annual Cost of Revenue growth rates for Sumitomo Pharma Co Ltd have been 2% over the past three years , -3% over the past five years , and -2% over the past ten years .

Back to Top